These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17105835)

  • 21. Comment on: linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
    De Beeck VO; Dhif N; Philipp J; De Bels D
    J Antimicrob Chemother; 2006 Mar; 57(3):577. PubMed ID: 16431858
    [No Abstract]   [Full Text] [Related]  

  • 22. Linezolid to decrease length of stay in the hospital for patients with methicillin-resistant Staphylococcus aureus infection.
    Siegel RE
    Clin Infect Dis; 2003 Jan; 36(1):124; author reply 124-5. PubMed ID: 12491215
    [No Abstract]   [Full Text] [Related]  

  • 23. No mercy for MRSA: treatment alternatives to vancomycin and linezolid.
    Wegner DL
    MLO Med Lab Obs; 2005 Jan; 37(1):26-9. PubMed ID: 15743145
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.
    Eckmann C; Lawson W; Nathwani D; Solem CT; Stephens JM; Macahilig C; Simoneau D; Hajek P; Charbonneau C; Chambers R; Li JZ; Haider S
    Int J Antimicrob Agents; 2014 Jul; 44(1):56-64. PubMed ID: 24928311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections.
    Bounthavong M; Hsu DI
    Expert Rev Pharmacoecon Outcomes Res; 2012 Dec; 12(6):683-98. PubMed ID: 23252352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment with linezolid of septic shock secondary to methicillin-resistant Staphylococcus aureus arthritis.
    De Bels D; Garcia-Filoso A; Jeanmaire M; Préseau T; Miendje Deyi VY; Devriendt J
    J Antimicrob Chemother; 2005 May; 55(5):812-3. PubMed ID: 15743893
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Estes L; Orenstein R
    Clin Ther; 2007 Feb; 29(2):381-3; author reply 383-4. PubMed ID: 17472831
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral antibiotic treatment for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: review of the literature.
    Khawcharoenporn T; Alan T
    Hawaii Med J; 2006 Oct; 65(10):290-3. PubMed ID: 17194061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections.
    Stein GE; Schooley S; Peloquin CA; Missavage A; Havlichek DH
    J Antimicrob Chemother; 2007 Oct; 60(4):819-23. PubMed ID: 17673476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.
    Gales AC; Sader HS; Andrade SS; Lutz L; Machado A; Barth AL
    Int J Antimicrob Agents; 2006 Apr; 27(4):300-2. PubMed ID: 16527459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid.
    Kessler AT; Kourtis AP
    Infection; 2007 Jun; 35(4):271-4. PubMed ID: 17646913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus.
    Phillips S; MacDougall C; Holdford DA
    Ann Pharmacother; 2007 Jan; 41(1):13-20. PubMed ID: 17200425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
    Maclayton DO; Hall RG
    Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
    Jørgen B; Merckoll P; Melby KK
    Scand J Infect Dis; 2007; 39(11-12):1059-62. PubMed ID: 17852934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linezolid resistance in coagulase-negative staphylococci.
    Kelly S; Collins J; Davin M; Gowing C; Murphy PG
    J Antimicrob Chemother; 2006 Oct; 58(4):898-9; author reply 899-900. PubMed ID: 16854956
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of community-acquired methicillin-resistant Staphylococcus aureus infection.
    de Almeida KN; Bush LM
    Ann Intern Med; 2006 Aug; 145(3):231-2; author reply 232-3. PubMed ID: 16880468
    [No Abstract]   [Full Text] [Related]  

  • 38. Eradication of pulmonary methicillin-resistant staphylococcus aureus (MRSA) in cystic fibrosis with linezolid.
    Serisier DJ; Jones G; Carroll M
    J Cyst Fibros; 2004 Mar; 3(1):61. PubMed ID: 15463889
    [No Abstract]   [Full Text] [Related]  

  • 39. Variability among pediatric infectious diseases specialists in the treatment and prevention of methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Creech CB; Beekmann SE; Chen Y; Polgreen PM
    Pediatr Infect Dis J; 2008 Mar; 27(3):270-2. PubMed ID: 18277924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.